Weaver C. Barksdale & Associates’s Cigna CI Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Buy	6,694 +419	+7%	+$116K	1.7%	29
2025 Q4	$1.73M	Buy	6,275 +4,200	+202%	+$1.18M	1.81%	24
2025 Q3	$598K	Hold	2,075	–	–	0.58%	62
2025 Q2	$686K	Buy	2,075 +216	+12%	+$69.6K	0.66%	62
2025 Q1	$612K	Hold	1,859	–	–	0.59%	62
2024 Q4	$513K	Hold	1,859	–	–	0.49%	62
2024 Q3	$644K	Hold	1,859	–	–	0.58%	62
2024 Q2	$615K	Hold	1,859	–	–	0.58%	62
2024 Q1	$675K	Hold	1,859	–	–	0.62%	62
2023 Q4	$557K	Hold	1,859	–	–	0.54%	62
2023 Q3	$532K	Buy	1,859 +1,062	+133%	+$303K	0.45%	62
2023 Q2	$224K	Hold	797	–	–	0.22%	62
2023 Q1	$204K	Sell	797 -6	-0.7%	-$1.75K	0.19%	62
2022 Q4	$266K	Buy	+803	New	+$254K	0.23%	61

Other funds holding CI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Weaver C. Barksdale & Associates's CI Position: Q1 2026 in Review

Weaver C. Barksdale & Associates increased its Cigna (CI) stake by 6.7% in Q1 2026, buying an estimated $116K and bringing the position to 6,694 shares worth $1.79M. The position accounts for 1.7% of the portfolio, ranked #29.

Weaver C. Barksdale & Associates first reported a position in CI in Q4 2022 and has held it in 14 quarters since. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

Weaver C. Barksdale & Associates held 6,694 shares of Cigna worth $1.79M as of Q1 2026.
Weaver C. Barksdale & Associates bought 419 Cigna shares in Q1 2026, an estimated $116K.
Cigna made up 1.7% of Weaver C. Barksdale & Associates's portfolio in Q1 2026, its #29 holding.
Weaver C. Barksdale & Associates first reported a position in Cigna in Q4 2022 and has held it in 14 quarters since.
1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2026, filed 14 May 2026.